Navigation Links
Genaera in Medical News

Xmark Comments on Genaera Cost-Saving Plan

RIDGEFIELD, Conn., May 9 /PRNewswire/ -- Xmark Opportunity Partners, LLC, the investment manager to Xmark Opportunity Fund, L.P., Xmark Opportunity Fund, Ltd. and Xmark JV Investment Partners, LLC, announced today that it fully supports the initiatives outlined in the press release issued by G...

DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller

...nce companies. Prior to joining DOR, he served in the senior financial roles for VioQuest Pharmaceuticals Inc., Micromet Inc., Cytogen Corporation and genaera Corporation, all publicly traded, R&D-focused companies in the biotechnology and specialty pharmaceuticals arenas. Mr. Schnittker also held manage...

Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust

...TH MEETING, Pa., June 12 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...fer of the Company's assets and liabilities to the genaera Liquidating Trust (the "Trust"). The Trust w...l interest ("Unit") in the Trust for each share of genaera common stock then held of record by such stockhold...

Genaera Corporation Announces Results of Special Meeting of Stockholders

...UTH MEETING, Pa., June 5 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...he Company (the "Plan of Dissolution). About genaera genaera Corporation has developed trodusquemine (MSI-1436)...

Genaera Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors

...H MEETING, Pa., April 28 /PRNewswire-FirstCall/ -- genaera Corporation (the "Company")(Nasdaq: GENR ) today...lso be obtained by directing a written request to: genaera Corporation, Attn: Secretary, 5110 Campus Drive, P...th respect to the Plan of Dissolution. About genaera ...

Genaera Corporation Implements Cash Conservation Plan

...H MEETING, Pa., March 30 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...dent and Chief Executive Officer of Genaera. genaera estimates that it will incur restructuring charges...h the reduction in force. As of December 31, 2008, genaera had cash, cash equivalents and short-term investme...

Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph

...TH MEETING, Pa., March 9 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced, in ...he Securities and Exchange Commission. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Corporation Announces 2008 Financial Results

...TH MEETING, Pa., March 3 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced its ...$8.1 million at December 31, 2008. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera to Present at BIO CEO & Investor Conference

...UTH MEETING, Pa., Feb. 5 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) will present at the ..., February 10, 2009 at 2:15 p.m. (ET). About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera to Participate in Obesity Panel at RBC Capital Markets Healthcare Conference

...UTH MEETING, Pa., Dec. 4 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that... www.wsw.com/webcast/rbc95/panel6 About genaera genaera Corporation is developing trodusquemine (MSI-1436)...
Genaera in Medical Technology

MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera

Broadens late-stage product development portfolio building on lead product candidate EcoNail in Phase 2 trial for onychomycosis WELLESLEY HILLS, Mass., Oct. 3 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) today announced that it has exercised the option it ...

Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)

...TH MEETING, Pa., Feb. 10 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today reported promi...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia

... MEETING, Pa., Jan. 22 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced a po...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics

...TH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...ekly subcutaneously administered formulation which genaera expects to utilize in Phase 2 clinical trials in t...bolism and cholesterol elevation. About genaera ...

Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an... phase 1 clinical testing in obesity. In addition, genaera has a value-driven, fully out-licensed partnership...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting

...pated in the Phase 1 clinical program of MSI-1436. genaera plans to conduct an ascending multiple-dose study ...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting

...y of Neuroscience by Mitchell F. Roitman, Ph.D., a genaera collaborator and investigator with the University ...ry R. Wolfe, Ph.D. from Genaera. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma

...e asthma and exercise-induced bronchoconstriction. genaera and MedImmune entered into a research collaboratio...t multiple sites throughout the U.S. and Canada. genaera also noted that MedImmune announced preliminary sa...he U.S. at $14 billion annually. About Genaera genaera Corporation is focused on advancing the science an...
Genaera in Biological News

Natural antibiotics yield secrets to atom-level imaging technique

...istry, the Medical School and the Biophysics Research Division, as well as collaborators in Canada, Japan, India and the U.S. pharmaceutical companies genaera Corporation and Eli Lilly and Company. Ramamoorthy was awarded support from the National Institutes of Health and the National Science Foundation, thr...
Genaera in Biological Technology

Genaera Receives Non-Compliance Notice from Nasdaq

...UTH MEETING, Pa., May 27 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...has received notification from Nasdaq stating that genaera is no longer in compliance with Nasdaq Marketplace...with Nasdaq's continued listing requirements. genaera previously announced on April 28, 2009 that its Bo...

Genaera to Present at BIO-Europe 2008

...overview on Tuesday, November 18, 2008 at 11:00 a.m. CET. About Genaera genaera Corporation is developing trodusquemine (MSI-1436) for type 2 diabetes and ...e to inaccurate assumptions, unknown risks, uncertainties or other factors. genaera does not intend (and it is not obligated) to publicly update, revise or cor...

Genaera Corporation Announces Second Quarter Financial Results

... $12.8 million at June 30, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Elects Paul K. Wotton to Board of Directors

...am very pleased to join Genaera's Board. I believe genaera has the opportunity to develop MSI-1436 as a novel...owing metabolic disease market." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Corporation to Present at BIO Business Forum

...iego Convention Center, Room 30A About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces First Quarter Financial Results

...$17.1 million at March 31, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces 2007 Financial Results

... be a pivotal year for Genaera." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference

...ing webcast at: http:/www.wsw.com/webcast/rbc84qpanel23 About Genaera genaera Corporation is focused on advancing the science and treatment of metabolic ...re program that is presently undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core program and the aggressive ...

Genaera Corporation Announces Third Quarter Financial Results

...estone targets to drive shareholder value." About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera to Present at Biotech 2007 and BIO InvestorForum

...(5:00 PM ET) on Thursday, October 11, 2007. About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...
Other Tags
(Date:7/9/2014)... Researchers at the Perelman School of Medicine at the ... Cancer Institute have received an $8 million grant from ... of photodynamic light therapy (PDT) in patients with malignant ... most often manifests itself in the lining of the ... asbestos. The grant will fund a clinical trial and ...
(Date:7/9/2014)... metabolism of stromal support cells and immune cells ... types in the development of diseases could open ... That was the conclusion of a review article by ... journal Nature . , Prof. Peter Carmeliet: "Consider ... metabolism of cancer cells has been examined in minute ...
(Date:7/9/2014)... N.Y. Although feelings are personal and subjective, ... code that objectively represents emotions across different senses, ... by Cornell University neuroscientist Adam Anderson. , "We ... the orbitofrontal cortex, an area of the brain ... code which captures an individual,s subjective feeling," says ...
(Date:7/9/2014)... Cup highlights, Brian Williams refreshing old school rap classics, ... railings. A University of Colorado Cancer Center study published ... YouTube also allows researchers, journals, and health advocates to ... cancer and prevention. , "No matter what field you,re ... communicate around the world," says Chante Karimkhani, MD candidate ...
(Date:7/9/2014)... labels handed out by pharmacists may be misread ... according to new research by the University of ... Blind)., The study, published recently in the ... prescription medications dispensed by pharmacies do not consistently ... simply following recommended guidelines for font size, use ...
Breaking Medicine News(10 mins):Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Wake-up call for more research into cell metabolism 2Health News:Study cracks how the brain processes emotions 2Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
(Date:7/9/2014)... one of the amphibians with the highest distribution in ... of water where it comes into contact with the ... carried out by the Spaniard Germn Orizaola from the ... these frogs have developed a defensive response to the ... bodies if they co-exist with the crayfish. , Numerous ...
(Date:7/9/2014)... function and increase the survival rate of naturally ... School of Pharmaceutical Sciences, Southwest University, China performed ... administered with low dose of levothyroxine for 3 ... exhibited an obvious improvement in cognitive and an ... The underlying mechanism was demonstrated that levothyroxine treatment ...
(Date:7/9/2014)... vitamin D in their blood are more likely to survive ... highest levels of vitamin D have half the risk of ... reveal. , The study is the first to correlate total ... their diagnosis which includes that produced after exposure to ... long term survival prospects. , The University of Edinburgh ...
Breaking Biology News(10 mins):Frogs have developed rapid defences against the red swamp crayfish 2Frogs have developed rapid defences against the red swamp crayfish 3
Other Contents